CDC IXIS Innovation
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 21, 2004
NewStar Financial
|
Debt Financing | $450M | Finance | Yes |
Jul 8, 2004
OneAccess
|
Series C | €7.50M | Manufacturing | Yes |
Mar 5, 2003
NEMOPTIC
|
Series C | $12M | Consumer | — |
Dec 5, 2002
Catalyst Bioscience
|
Series Unknown | $46M | Biotechnology | — |
Nov 5, 2002
Kuros Biosciences
|
Series A | €7M | Biopharma | — |
CDC IXIS Innovation has had 4 exits. CDC IXIS Innovation most notable exits include OneAccess , Kuros Biosciences
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 4, 2017 | OneAccess | M&A | Manufacturing | Detail |
Jan 22, 2016 | Kuros Biosciences | IPO | Biopharma | Detail |
Dec 15, 2006 | NewStar Financial | M&A | Finance | Detail |
Apr 21, 2006 | Catalyst Bioscience | IPO | Biotechnology | Detail |